Central histaminergic signalling, neural excitability and epilepsy

Br J Pharmacol. 2022 Jan;179(1):3-22. doi: 10.1111/bph.15692. Epub 2021 Nov 9.

Abstract

Epilepsy is a common neurological disorder characterized by repeated and spontaneous epileptic seizures and is not well controlled by current medication. Traditional theory suggests that epilepsy results from an imbalance of excitatory glutamate neurons and inhibitory GABAergic neurons. However, new evidence from clinical and preclinical research suggests that histamine in the CNS plays an important role in the modulation of neural excitability and in the pathogenesis of epilepsy. Many histamine receptor ligands have achieved curative effects in animal epilepsy models, among which the histamine H3 receptor antagonist pitolisant has shown anti-epileptic effects in clinical trials. Recent studies, therefore, have focused on the potential action of histamine receptors to control and treat epilepsy. In this review, we summarize the findings from animal and clinical epilepsy research on the role of brain histamine and its receptors. We also identify current gaps in the research and suggest where further studies are most needed.

Keywords: central nervous system; epilepsy; histamine; histamine receptor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anticonvulsants / pharmacology
  • Brain / metabolism
  • Epilepsy* / drug therapy
  • Histamine / pharmacology
  • Histamine Antagonists / pharmacology
  • Receptors, Histamine H3*

Substances

  • Anticonvulsants
  • Histamine Antagonists
  • Receptors, Histamine H3
  • Histamine